- Report
- November 2025
- 479 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 464 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 475 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 186 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 381 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 378 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 276 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 294 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 370 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 377 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 473 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 485 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 282 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 588 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 474 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 461 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 276 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 485 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 467 Pages
Global
From €5227EUR$5,850USD£4,608GBP
- Report
- November 2025
- 182 Pages
Global
From €5227EUR$5,850USD£4,608GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more